ANIK
Anika Therapeutics Inc.
$14.90
+$0.09(+0.61%)
57
Overall
60
Value
66
Tech
47
Quality
Market Cap
$142.05M
Volume
113.67K
52W Range
$7.87 - $16.24
Target Price
$19.67
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $103.4M | $113.4M | $105.6M | $114.6M | $130.5M | $147.8M | $156.2M | $120.8M | $119.9M | $112.8M | ||
| Total Revenue | $102.9M | $113.4M | $105.6M | $114.6M | $130.5M | $147.8M | $156.2M | $120.8M | $119.9M | $112.8M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-24.0M | $-27.4M | $-31.3M | $28.7M | $61.4M | $64.9M | $62.7M | $38.3M | $43.9M | $49.0M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $79.4M | $86.1M | $74.3M | $85.9M | $69.0M | $82.9M | $93.6M | $82.5M | $76.0M | $63.8M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $28.7M | $40.3M | $52.5M | $51.6M | $83.5M | $101.4M | $113.0M | $81.7M | $81.1M | $74.9M | ||
| Research & Development | $10.7M | $18.8M | $18.2M | $16.7M | $23.4M | $27.3M | $28.2M | $21.8M | $25.5M | $25.8M | ||
| Research Expense | $10.7M | $18.8M | $18.2M | $16.7M | $23.4M | $27.3M | $28.2M | $21.8M | $25.5M | $25.8M | ||
| Selling, General & Administrative | $18.0M | $21.5M | $34.3M | $35.0M | $60.1M | $74.1M | $84.8M | $59.9M | $55.6M | $49.1M | ||
| Selling & Marketing Expenses | $18.0M | $21.5M | $34.3M | -- | -- | -- | -- | -- | -- | -- | ||
| General & Administrative Expenses | $-1.3M | $-1.8M | $-1.8M | $35.0M | $60.1M | $74.1M | $84.8M | $59.9M | $55.6M | $49.1M | ||
| Salaries & Wages | $-3.4M | $-5.8M | $-11.0M | $-100.0K | $-200.0K | $-100.0K | -- | -- | -- | -- | ||
| Depreciation & Amortization | $-2.7M | $-3.3M | $-4.9M | $5.0M | $6.1M | $6.5M | $6.7M | $6.4M | $6.9M | -- | ||
| Depreciation & Amortization | $-2.7M | $-3.3M | $-4.9M | $5.0M | $6.1M | $6.5M | -- | -- | -- | -- | ||
| Amortization | $-1.1M | $-1.0M | $-1.0M | $7.7M | $91.3M | $82.5M | $74.7M | $9.8M | $9.3M | -- | ||
| Other Operating Expenses | $-52.0K | $-1.6M | $-57.0K | $2.3M | -- | $3.0M | -- | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $50.6M | $45.7M | $21.7M | $34.2M | $-28.3M | $2.6M | $-19.4M | $844.0K | $-5.1M | $-11.1M | ||
| EBITDA | $54.6M | $50.5M | $29.1M | $43.3M | $-1.0M | $-4.2M | $-2.4M | $9.5M | $-43.6M | $-4.5M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | -- | $25.0K | $19.0K | -- | $-2.3M | $-2.3M | $-1.7M | ||
| Intinc | $263.0K | $473.0K | $1.5M | $1.9M | $-302.0K | $-188.0K | $654.0K | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $263.0K | $473.0K | $1.5M | $1.9M | $-302.0K | $-188.0K | $654.0K | $2.3M | $2.3M | $1.7M | ||
| Other Income/Expense | $-16.0K | $-906.0K | $-360.0K | $-158.2M | $-28.7M | $-21.1M | $-180.0K | $-105.0K | $-65.0K | -- | ||
| Other Special Charges | -- | $900.0K | -- | -- | -- | -- | -- | -- | -- | -- | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | -- | -- | $-7.1M | $23.0M | -- | -- | -- | -- | -- | ||
| Special Income Charges | -- | -- | -- | $7.1M | $-42.5M | -- | -- | $-62.2M | $-2.5M | -- | ||
| Impairment of Capital Assets | -- | -- | -- | $389.0K | $42.5M | -- | -- | $62.2M | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $50.9M | $46.2M | $23.2M | $36.1M | $-14.5M | $-18.5M | $-18.7M | $844.0K | $-52.7M | $-12.0M | ||
| Pre-Tax Income | $50.9M | $46.2M | $23.2M | $36.1M | $-28.6M | $2.4M | $-18.7M | $3.2M | $-2.8M | $-9.3M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $18.3M | $14.4M | $4.5M | $8.9M | $-4.6M | $-1.7M | $-3.9M | $6.6M | $6.1M | $672.0K | ||
| NET INCOME | ||||||||||||
| Net Income | $32.5M | $31.8M | $18.7M | $27.2M | $-24.0M | $4.1M | $-14.9M | $-82.7M | $-56.4M | $-10.9M | ||
| Net Income (Continuing Operations) | $32.5M | $31.8M | $18.7M | $27.2M | $-24.0M | $4.1M | $-14.9M | $-3.4M | $-56.4M | $-10.9M | ||
| Net Income (Discontinued Operations) | $32.5M | $31.8M | $18.7M | $27.2M | $-24.0M | $4.1M | $-14.9M | $-82.7M | $-56.4M | $-10.9M | ||
| Net Income (Common Stockholders) | $32.5M | $31.8M | $18.7M | $27.2M | $-24.0M | $4.1M | $-14.9M | $-82.7M | $-56.4M | $-10.9M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-9.2M | ||
| TOTALS | ||||||||||||
| Total Expenses | $4.7M | $13.0M | $21.2M | $80.4M | $144.9M | $166.3M | $175.6M | $119.9M | $125.0M | $123.9M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $14.7M | $14.6M | $14.4M | $14.1M | $14.2M | $14.4M | $14.6M | $14.7M | $14.7M | $14.3M | ||
| Average Shares Outstanding (Diluted) | $15.1M | $15.1M | $14.7M | $14.4M | $14.2M | $14.6M | $14.6M | $14.7M | $14.7M | $14.3M | ||
| Shares Outstanding | $14.6M | $14.7M | $14.2M | $14.2M | $14.3M | $14.5M | $14.6M | $14.8M | $14.2M | $13.4M | ||
| Basic EPS | $2.22 | $2.18 | $1.3 | $1.93 | $-1.69 | $0.29 | $-1.02 | $-5.64 | $-3.83 | $-0.76 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | $1.93 | $-1.69 | $0.29 | $-1.02 | $-5.64 | $-0.60 | $-0.70 | ||
| Diluted EPS | $2.15 | $2.11 | $1.27 | $1.89 | $-1.69 | $0.28 | $-1.02 | $-5.64 | $-3.83 | $-0.76 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $1.89 | $-1.69 | $0.28 | $-1.02 | $-5.64 | $-0.60 | $-0.70 | ||
| OTHER METRICS | ||||||||||||
| Basic Discontinuous Operations | -- | -- | -- | -- | -- | -- | -- | -- | $-3.23 | $-0.06 | ||
| Diluted Discontinuous Operations | -- | -- | -- | -- | -- | -- | -- | -- | $-3.23 | $-0.06 | ||
| Net Income Discontinuous Operations | -- | $9.8M | -- | -- | -- | -- | -- | $-79.2M | $-47.6M | -- | ||
| Other Gand A | $-1.3M | $-1.8M | $-1.8M | $35.0M | $60.1M | $74.1M | $84.8M | $59.9M | $55.6M | $49.1M | ||
| Other Write Off | $-16.0K | $-6.0K | $-360.0K | $-505.0K | $-86.0K | $-92.0K | -- | -- | -- | -- | ||
| Provision For Gain Loss On Disposal | -- | $9.8M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $-1.3M | $-1.8M | $-1.8M | -- | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $18.0M | $21.5M | $34.3M | -- | -- | -- | -- | -- | -- | -- | ||
| Restruct | -- | -- | -- | $-7.1M | $23.0M | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ANIK | $14.90 | +0.6% | 113.67K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |